Clinical Trial Update: To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ceftriaxone for efficacy and safety in patients with Parkinson's disease dementia; trial status is active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease Dementia

Drugs mentioned

• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: BrainX Corporation | Conditions: Parkinson's Disease Dementia | Phase 2 | Status: ACTIVE_NOT_RECRUITING